-transparent.png){kind=logo}
Plasma interleukin-1 beta (IL-1 beta) concentrations were measured in 10 outpatients with panic disorder before and on days 30 and 32 of treatment with alprazolam (2-2.5 mg/day). IL-1 beta concentrations were found to be significantly higher in patients than in control subjects both before and during therapy. Thus, IL-1 beta levels may be a marker of panic disorder that is not related to the current level of symptomatology.
Related Publications
F Brambilla, and
L Bellodi, and
G Perna, and
A Bertani, and
A Panerai, and
P Sacerdote
April 1990,
The American journal of psychiatry,
F Brambilla, and
L Bellodi, and
G Perna, and
A Bertani, and
A Panerai, and
P Sacerdote
June 2005,
Psychiatry research,
F Brambilla, and
L Bellodi, and
G Perna, and
A Bertani, and
A Panerai, and
P Sacerdote
November 1992,
The American journal of psychiatry,
F Brambilla, and
L Bellodi, and
G Perna, and
A Bertani, and
A Panerai, and
P Sacerdote
May 1996,
Clinical and diagnostic laboratory immunology,
F Brambilla, and
L Bellodi, and
G Perna, and
A Bertani, and
A Panerai, and
P Sacerdote
June 1993,
Der Anaesthesist,
F Brambilla, and
L Bellodi, and
G Perna, and
A Bertani, and
A Panerai, and
P Sacerdote
February 2007,
Therapeutic drug monitoring,
F Brambilla, and
L Bellodi, and
G Perna, and
A Bertani, and
A Panerai, and
P Sacerdote
December 1987,
Biological psychiatry,
F Brambilla, and
L Bellodi, and
G Perna, and
A Bertani, and
A Panerai, and
P Sacerdote
January 2001,
Neuroimmunomodulation,
F Brambilla, and
L Bellodi, and
G Perna, and
A Bertani, and
A Panerai, and
P Sacerdote
October 1992,
Biological psychiatry,
F Brambilla, and
L Bellodi, and
G Perna, and
A Bertani, and
A Panerai, and
P Sacerdote
August 2012,
Journal of affective disorders,
